First-ever phase-three clinical trial for dengue vaccine initiated in India Deccan HeraldPanacea Biotec shares up 5% as phase-3 trial of India’s first dengue vaccine ‘DengiAll’ begins UpstoxICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll MintICMR, Panacea Biotec begin Phase 3 clinical trial of indigenous dengue vaccine ETHealthWorldICMR, Panacea Biotec initiate 1st ever phase-three clinical trial for dengue vaccine in India Moneycontrol First-ever phase-three clinical trial for dengue vaccine initiated in India Deccan HeraldPanacea Biotec shares up 5% as phase-3 trial of India’s first dengue vaccine ‘DengiAll’ begins UpstoxICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll MintICMR, Panacea Biotec begin Phase 3 clinical trial of indigenous dengue vaccine ETHealthWorldICMR, Panacea Biotec initiate 1st ever phase-three clinical trial for dengue vaccine in India Moneycontrol Top stories – Google News